Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_assertion type Assertion NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_head.
- NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_assertion description "[In this review, we outline these findings including: molecular pathways used by BRAF, the importance in nonmalignant neoplasms, histologic associations, the relationship of BRAF to KIT and NRAS mutations, and their impact on survival, as well as resistance mechanisms to BRAF inhibitors employed by melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_provenance.
- NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_assertion evidence source_evidence_literature NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_provenance.
- NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_assertion SIO_000772 23414474 NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_provenance.
- NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_assertion wasDerivedFrom befree-2016 NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_provenance.
- NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_assertion wasGeneratedBy ECO_0000203 NP1053409.RASUb1znd1ej27RE8k9A9taQJwRAnLaflRKCzhLe6Zh2U130_provenance.